PROVIDER PROFILE · NPI 1063654465
Stacey Warneke
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
2,705
Beneficiaries
—
Total drug cost
$533K
Distinct drugs
68
Brand share
33.8%
Top prescribed drugs
Dulaglutide169 claims
Rosuvastatin Calcium145 claims
Omeprazole118 claims
Atorvastatin Calcium111 claims
Levothyroxine Sodium110 claims
QUALITY · MIPS · 2024
Final MIPS score
95.6
Quality
94.8
Cost
0.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.87%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$422
Payment records
18
By payment type
Food and Beverage$422
Top paying entities
Food and Beverage$422
REFERRAL NETWORK
Where Stacey Warneke's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 1 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Labone Llc Clinical Laboratory · Lenexa, KS | 15 | 23 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE